At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 47 enrolled
Drug / intervention
Comparator: amlodipine besylate +1 moredrug
Likely dose
Comparator: amlodipine besylate 5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Clinical Trial to Evaluate the Effects of Multiple Doses of Amlodipine 10 mg on Pedal Edema Measurements in Middle-Aged and Elderly Healthy Subjects and Patient With Hypertension
In Brief
A Phase 1 clinical trial evaluating Comparator: amlodipine besylate and Comparator: Placebo for Hypertension. Completed, enrolled 47 participants.
Detailed Summary
This study will evaluate methodologies for measuring pedal edema associated with calcium channel blockers in middle-aged and elderly subjects and patients with hypertension.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
Countries--
Collaborators--
Timeline
Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2008
First PostedNov 2008
Primary CompletionFeb 2009
Study CompletionMar 2009
TodayJul 2026
First PostedNov 11, 2008
Enrollment StartJul 1, 2008
Primary CompletionFeb 1, 2009
Study CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 17.6 years ago
Interventions
Comparator: amlodipine besylatedrug
Two 5 mg tablets amlodipine daily for 6 weeks.
Comparator: Placebodrug
Two 5 mg tablets placebo to amlodipine daily for 6 weeks